Overview

Single-Cell Genome Sequencing Market is poised to register a CAGR of 14.6% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Single-Cell Genome Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Single-Cell Genome Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Single-Cell Genome Sequencing Market:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• QIAGEN
• Bio-Rad Laboratories
• 10x Genomics
• Novogene
• Fludigim
• BGI
• Illumina, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences
(Note: The list of the major players will be updated with the latest market scenario and trends)

Single-Cell Genome Sequencing Market Segmentation:
By Product Type
• Instruments
• Reagents

By Technology
• NGS
• PCR
• qPCR
• Microarray
• MDA

By Workflow
• Single-cell isolation
• Sample preparation
• Genomic analysis

By Disease Area
• Cancer
• Immunology
• Prenatal diagnosis
• Neurobiology
• Microbiology
• Others

By Application
• Circulating cells
• Cell differentiation/reprogramming
• Genomic variation
• Subpopulation characterization
• Others

By End User
• Academic & research laboratories
• Biotechnology & biopharmaceutical companies
• Clinics
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Single-Cell Genome Sequencing Market By Product Type, By Technology, By Workflow, By Disease Area,  By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

 2. Research Methodology 
    2.1 Research Data 
        2.1.1 Secondary Data
              2.1.1.1 Key Data from Secondary Sources
        2.1.2 Primary Data
              2.1.2.1 Key Data from Primary Sources
    2.2 Market Size Estimation 
    2.3 Market Breakdown and Data Triangulation 
    2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4. Global Single-Cell Genome Sequencing Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Single-Cell Genome Sequencing Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Single-Cell Genome Sequencing Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Single-Cell Genome Sequencing Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Instruments
   7.2. Reagents
 
8. Global Single-Cell Genome Sequencing Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
   8.1. NGS
   8.2. PCR
   8.3. qPCR
   8.4. Microarray
   8.5. MDA

9. Global Single-Cell Genome Sequencing Market, By Workflow Historical Analysis and Forecast 2022-2028 (USD Million)
   9.1. Single-cell isolation
   9.2. Sample preparation
   9.3. Genomic analysis

10. Global Single-Cell Genome Sequencing Market, By Disease Area Historical Analysis and Forecast 2022-2028 (USD Million)
   10.1. Cancer
   10.2. Immunology
   10.3. Prenatal diagnosis
   10.4. Neurobiology
   10.5. Microbiology
   10.6. Others
 
11. Global Single-Cell Genome Sequencing Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
   11.1. Circulating cells
   11.2. Cell differentiation/reprogramming
   11.3. Genomic variation
   11.4. Subpopulation characterization
   11.5. Others

12. Global Single-Cell Genome Sequencing Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
   12.1. Academic & research laboratories
   12.2. Biotechnology & biopharmaceutical companies
   12.3. Clinics
   12.4. Others

13. North America Single-Cell Genome Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
        13.2.1. U.S.A
        13.2.2. Canada
        13.2.3. Mexico
   13.3. Market Size (USD Million) Forecast for North America 2022-2028

14. Latin America Single-Cell Genome Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Brazil
          14.2.2. Venezuela
          14.2.3. Argentina
          14.2.4. Rest of Latin America
    14.3. Market Size (USD Million) Forecast for Latin America 2022-2028

15. Europe Single-Cell Genome Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Germany
          15.2.2. U.K         
          15.2.3. France
          15.2.4. Italy
          15.2.5. Spain
          15.2.6. Russia
          15.2.7. Poland
          15.2.8. Rest of Europe
    15.3. Market Size (USD Million) Forecast for Europe 2022-2028

16. Asia Pacific Single-Cell Genome Sequencing Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. Japan
          16.2.2. China
          16.2.3. India
          16.2.4. Australia and New Zealand
          16.2.5. ASEAN
          16.2.6. Rest of Asia Pacific
    16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
    17.1. Introduction
    17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          17.2.1. GCC
          17.2.2. Israel
          17.2.3. South Africa
          17.2.4. Rest of MEA
    17.3. Market Size (USD Million) Forecast for MEA 2022-2028

18. Market Share Analysis and Competitive Landscape   
    18.1. Global Landscape - Key Players, Revenue and Presence
    18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    18.3. Global Emerging Companies
    18.4.  North America - Market Share Analysis and Key Regional Players
    18.5.  Europe - Market Share Analysis and Key Regional Players
    18.6.  Asia Pacific - Market Share Analysis and Key Regional Players
    18.7.  Global Key Player - Growth Matrix

19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    19.1. F. Hoffmann-La Roche Ltd.
          19.1.1. Company Overview
          19.1.2. Product Portfolio
          19.1.3. SWOT Analysis
          19.1.4. Financial Overview
          19.1.5. Strategic Overview
    19.2. Thermo Fisher Scientific, Inc.
          19.2.1. Company Overview
          19.2.2. Product Portfolio
          19.2.3. SWOT Analysis
          19.2.4. Financial Overview
          19.2.5. Strategic Overview 
    19.3. QIAGEN
          19.3.1. Company Overview
          19.3.2. Product Portfolio
          19.3.3. SWOT Analysis
          19.3.4. Financial Overview
          19.3.5. Strategic Overview
    19.4. Bio-Rad Laboratories
          19.4.1. Company Overview
          19.4.2. Product Portfolio
          19.4.3. SWOT Analysis
          19.4.4. Financial Overview
          19.4.5. Strategic Overview
    19.5. 10x Genomics
          19.5.1. Company Overview
          19.5.2. Product Portfolio
          19.5.3. SWOT Analysis
          19.5.4. Financial Overview
          19.5.5. Strategic Overview          
    19.6. Novogene
          19.6.1. Company Overview
          19.6.2. Product Portfolio
          19.6.3. SWOT Analysis
          19.6.4. Financial Overview
          19.6.5. Strategic Overview      
    19.7. Fludigim
          19.7.1. Company Overview
          19.7.2. Product Portfolio
          19.7.3. SWOT Analysis
          19.7.4. Financial Overview
          19.7.5. Strategic Overview
    19.8. BGI
          19.8.1. Company Overview
          19.8.2. Product Portfolio
          19.8.3. SWOT Analysis
          19.8.4. Financial Overview
          19.8.5. Strategic Overview 
    19.9. Illumina, Inc.
          19.9.1. Company Overview
          19.9.2. Product Portfolio
          19.9.3. SWOT Analysis
          19.9.4. Financial Overview
          19.9.5. Strategic Overview
    19.10. Oxford Nanopore Technologies
          19.10.1. Company Overview
          19.10.2. Product Portfolio
          19.10.3. SWOT Analysis
          19.10.4. Financial Overview
          19.10.5. Strategic Overview
    19.11.Pacific Biosciences
          19.11.1. Company Overview
          19.11.2. Product Portfolio
          19.11.3. SWOT Analysis
          19.11.4. Financial Overview
          19.11.5. Strategic Overview

20. Pre and Post COVID-19 Impact
    20.1. Positive influence on the healthcare industry
    20.2. The financial disruption of the manufacturing sector
    20.3. Impact of COVID-19 on emerging companies
    20.4. Significant mandates in the healthcare regulations initiated by administrations
    20.5. The overall economic slowdown of the developing and developed nations

21. FutureWise SME Key Takeaway Points for Client

Tables

Figures